Defibrotide
Showing 1 - 25 of 29
Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial (Defibrotide)
Not yet recruiting
- Sinusoidal Obstruction Syndrome
- Veno-occlusive Disease
- Defibrotide
- (no location specified)
Aug 4, 2023
Sickle Cell Disease, Acute Chest Syndrome Trial in Valhalla (Defibrotide)
Active, not recruiting
- Sickle Cell Disease
- Acute Chest Syndrome
- Defibrotide
-
Valhalla, New YorkNew York Medical College
Oct 24, 2022
Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure Trial in Milano
Completed
- Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure
- Defibrotide Injection
-
Milano, Lombardia, ItalyOspedale San Raffaele
Jul 18, 2022
COVID19 Trial in Spain (Defibrotide, Placebo)
Recruiting
- COVID19
- Defibrotide
- Placebo
-
Cartagena, Murcia, Spain
- +7 more
Jun 28, 2022
Sickle Cell Disease Trial in United States (Defibrotide)
Recruiting
- Sickle Cell Disease
- Defibrotide
-
Los Angeles, California
- +3 more
Mar 29, 2022
COVID, Sars-CoV2, COVID-19 Trial in Ann Arbor (Defibrotide)
Completed
- COVID
- +3 more
- Defibrotide
-
Ann Arbor, MichiganUniversity of Michigan
Nov 10, 2021
Thrombotic Microangiopathies Trial in San Francisco (Defibrotide)
Completed
- Thrombotic Microangiopathies
- Defibrotide
-
San Francisco, CaliforniaBenioff Children's Hospital at UCSF Medical Center
Sep 14, 2021
Covid19 Trial in Boston (Defibrotide)
Recruiting
- Covid19
- Defibrotide
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 23, 2021
DLBCL, Neurotoxicity Syndromes Trial in United States (Defibrotide)
Terminated
- DLBCL
- Neurotoxicity Syndromes
- Defibrotide
-
Phoenix, Arizona
- +4 more
Nov 10, 2021
Sinusoidal Obstruction Syndrome, Veno-occlusive Disease, Bone Marrow Transplant Complications Trial in Maywood (Defibrotide)
Recruiting
- Sinusoidal Obstruction Syndrome
- +2 more
- Defibrotide
-
Maywood, IllinoisLoyola University Medical Center
Apr 22, 2021
Graft-versus-host Disease, Acute-graft-versus-host Disease Trial in Worldwide (Defibrotide, Standard of Care)
Completed
- Graft-versus-host Disease
- Acute-graft-versus-host Disease
- Defibrotide
- Standard of Care
-
Los Angeles, California
- +61 more
Jul 26, 2021
Veno-occlusive Disease Trial in Worldwide (Defibrotide, Best Supportive Care)
Completed
- Veno-occlusive Disease
- Defibrotide
- Best Supportive Care
-
Birmingham, Alabama
- +113 more
Feb 4, 2022
Healthy Volunteers, Endotoxemia Trial in Vienna (Defibrotide, Placebo (0.9% sodium chloride), Lipopolysaccharide)
Completed
- Healthy Volunteers
- Endotoxemia
- Defibrotide
- +3 more
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Dec 2, 2019
Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial in Kansas City (Ultrasound
Active, not recruiting
- Bone Marrow Transplant Complications
- +3 more
- Ultrasound Examination
-
Kansas City, MissouriChildren's Mercy Hospital
Jun 3, 2022
Sinusoidal Obstruction Syndrome for Stem Cell Transplant
Active, not recruiting
- Sinusoidal Obstruction Syndrome
- Serial Blood Draws
-
Washington, District of Columbia
- +3 more
Aug 1, 2022
Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic Trial in Kansas City
Recruiting
- Bone Marrow Transplant Complications
- +3 more
- Ultrasound Elastography
-
Kansas City, MissouriAmie Robinson
Oct 26, 2021
Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic, Bone Marrow Transplant Complications Trial in Kansas City
Withdrawn
- Sinusoidal Obstruction Syndrome
- +3 more
- Ultrasound Elastography
- Contrast Enhanced Ultrasound (CEUS)
-
Kansas City, MissouriChildren's Mercy Hospital
Jan 8, 2020
European VOD Registry
Completed
- Hepatic Veno-Occlusive Disease
-
Angers, France
- +52 more
Oct 14, 2019
Rivaroxaban for Intermittent Claudication and Exercise Tolerance
Not yet recruiting
- Peripheral Arterial Disease
- (no location specified)
Mar 8, 2021
Hepatic Veno-occlusive Disease Trial in Memphis (Defibrotide)
No longer available
- Hepatic Veno-occlusive Disease
- Defibrotide
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 24, 2017
Hepatic Veno-Occlusive Disease Trial in United States (Defibrotide)
Completed
- Hepatic Veno-Occlusive Disease
- Defibrotide
-
Birmingham, Alabama
- +124 more
Nov 2, 2017
Veno-occlusive Disease Trial in United States (defibrotide)
Completed
- Veno-occlusive Disease
- defibrotide
-
Duarte, California
- +8 more
Jan 19, 2017
Severe Hepatic Veno-Occlusive Disease Trial in Canada, United States (Defibrotide)
Completed
- Severe Hepatic Veno-Occlusive Disease
- Defibrotide
-
Duarte, California
- +24 more
Dec 2, 2016
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplasia Trial in Memphis (drug, device, procedure)
Completed
- Acute Myeloid Leukemia
- +4 more
- Chemotherapy and antibodies
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 25, 2017